======= HOXD10 =======
== Gene Information ==
* **Official Symbol**: HOXD10
* **Official Name**: homeobox D10
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3236|3236]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P28358|P28358]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=HOXD10&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HOXD10|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/142984|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene is a member of the Abd-B homeobox family and encodes a protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox D genes located on chromosome 2. The encoded nuclear protein functions as a sequence-specific transcription factor that is expressed in the developing limb buds and is involved in differentiation and limb development. Mutations in this gene have been associated with Wilm's tumor and congenital vertical talus (also known as 'rocker-bottom foot' deformity or congenital convex pes valgus) and/or a foot deformity resembling that seen in Charcot-Marie-Tooth disease. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis.
|Homeobox|
|peripheral nervous system neuron differentiation|
|peripheral nervous system neuron development|
|spinal cord motor neuron cell fate specification|
|proximal/distal pattern formation|
|neuron fate specification|
|spinal cord motor neuron differentiation|
|hindlimb morphogenesis|
|forelimb morphogenesis|
|ventral spinal cord development|
|cell differentiation in spinal cord|
|neuron fate commitment|
|cytoplasmic ribonucleoprotein granule|
|peripheral nervous system development|
|adult locomotory behavior|
|cell fate specification|
|embryonic skeletal system morphogenesis|
|spinal cord development|
|neuromuscular process|
|skeletal muscle tissue development|
|embryonic limb morphogenesis|
|embryonic appendage morphogenesis|
|embryonic skeletal system development|
|skeletal muscle organ development|
|single fertilization|
|adult behavior|
|limb morphogenesis|
|appendage morphogenesis|
|fertilization|
|central nervous system neuron differentiation|
|appendage development|
|limb development|
|locomotory behavior|
|anterior/posterior pattern specification|
|skeletal system morphogenesis|
|cell fate commitment|
|striated muscle tissue development|
|embryonic organ morphogenesis|
|muscle organ development|
|muscle tissue development|
|RNA polymerase II regulatory region sequence-specific DNA binding|
|regionalization|
|chromatin binding|
|embryonic organ development|
|pattern specification process|
|DNA-binding transcription activator activity, RNA polymerase II-specific|
|muscle structure development|
|skeletal system development|
|embryonic morphogenesis|
|behavior|
|chordate embryonic development|
|embryo development ending in birth or egg hatching|
|neuron development|
|sexual reproduction|
|animal organ morphogenesis|
|embryo development|
|central nervous system development|
|multi-organism reproductive process|
|neuron differentiation|
|positive regulation of transcription by RNA polymerase II|
|nervous system process|
|reproductive process|
|reproduction|
|generation of neurons|
|positive regulation of transcription, DNA-templated|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|neurogenesis|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|cell development|
|positive regulation of RNA metabolic process|
|tissue development|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|system process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|1.79|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|1/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7206
* **Expression level (log2 read counts)**: -4.27
{{:chemogenomics:nalm6 dist.png?nolink |}}